
RU-486, Status Report on the U.S. Commercialization Project, Transfer of Antiprogestin Technology to the United States: Hearing Before the Subcommitte
Versandkostenfrei!
Versandfertig in über 4 Wochen
15,99 €
inkl. MwSt.
PAYBACK Punkte
8 °P sammeln!
RU-486, Status Report on the U.S. Commercialization Project, Transfer of Antiprogestin Technology to the United States: Hearing Before the Subcommitte